Torulopsis glabrata urinary tract infection treated with 5-fluorocytosine.
Two diabetic patients with symptomatic urinary tract infection by Torulopsis glabrata were successfully treated with two-week courses of 5-fluorocytosine.
D000368:Aged; D000917:Antibody Formation; D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects* / Q000276:immunology / Q000302:isolation & purification; D003596:Cytosine / Q000008:administration & dosage / Q000627:therapeutic use*; D048909:Diabetes Complications; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D011776:Pyuria / Q000382:microbiology; D001743:Urinary Bladder / Q000473:pathology; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy*; D014621:Vagina / Q000382:microbiology
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine